These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 38540795)
1. Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes. Gascón E; Zaragoza P; Calvo AC; Osta R Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540795 [TBL] [Abstract][Full Text] [Related]
2. Identification of let-7f and miR-338 as plasma-based biomarkers for sporadic amyotrophic lateral sclerosis using meta-analysis and empirical validation. Daneshafrooz N; Joghataei MT; Mehdizadeh M; Alavi A; Barati M; Panahi B; Teimourian S; Zamani B Sci Rep; 2022 Jan; 12(1):1373. PubMed ID: 35082326 [TBL] [Abstract][Full Text] [Related]
3. Differential Expression of MicroRNAs and Predicted Drug Target in Amyotrophic Lateral Sclerosis. Patel RB; Bajpai AK; Thirumurugan K J Mol Neurosci; 2023 Jun; 73(6):375-390. PubMed ID: 37249795 [TBL] [Abstract][Full Text] [Related]
4. Identification of a circulating miRNA signature in extracellular vesicles collected from amyotrophic lateral sclerosis patients. Saucier D; Wajnberg G; Roy J; Beauregard AP; Chacko S; Crapoulet N; Fournier S; Ghosh A; Lewis SM; Marrero A; O'Connell C; Ouellette RJ; Morin PJ Brain Res; 2019 Apr; 1708():100-108. PubMed ID: 30552897 [TBL] [Abstract][Full Text] [Related]
5. Three nervous system-specific expressed genes are potential biomarkers for the diagnosis of sporadic amyotrophic lateral sclerosis through a bioinformatic analysis. Liao Y; Cai H; Luo F; Li D; Li H; Liao G; Duan J; Xu R; Zhang X BMC Med Genomics; 2023 Jan; 16(1):15. PubMed ID: 36707813 [TBL] [Abstract][Full Text] [Related]
6. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis. Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-5572 Is a Novel MicroRNA-Regulating Kurita H; Yabe S; Ueda T; Inden M; Kakita A; Hozumi I Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599739 [TBL] [Abstract][Full Text] [Related]
8. Two distinct skeletal muscle microRNA signatures revealing the complex mechanism of sporadic ALS. Aksu-Menges E; Balci-Hayta B; Bekircan-Kurt CE; Aydinoglu AT; Erdem-Ozdamar S; Tan E Acta Neurol Belg; 2022 Dec; 122(6):1499-1509. PubMed ID: 34241798 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles and protein-protein interaction networks in amyotrophic lateral sclerosis patients with C9orf72 mutation. Kotni MK; Zhao M; Wei DQ Orphanet J Rare Dis; 2016 Nov; 11(1):148. PubMed ID: 27814735 [TBL] [Abstract][Full Text] [Related]
10. Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels. Campos-Melo D; Droppelmann CA; He Z; Volkening K; Strong MJ Mol Brain; 2013 May; 6():26. PubMed ID: 23705811 [TBL] [Abstract][Full Text] [Related]
11. New insights into the gene expression associated to amyotrophic lateral sclerosis. Recabarren-Leiva D; Alarcón M Life Sci; 2018 Jan; 193():110-123. PubMed ID: 29241710 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs and HDAC4 protein expression in the skeletal muscle of ALS patients. Pegoraro V; Marozzo R; Angelini C Clin Neuropathol; 2020; 39(3):105-114. PubMed ID: 32000889 [TBL] [Abstract][Full Text] [Related]
13. Screening and identification of key biomarkers associated with amyotrophic lateral sclerosis and depression using bioinformatics. Wang Z; Yang H; Han Y; Teng J; Kong X; Qi X Medicine (Baltimore); 2023 Nov; 102(47):e36265. PubMed ID: 38013317 [TBL] [Abstract][Full Text] [Related]
15. Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis. Chen Y; Wei Q; Chen X; Li C; Cao B; Ou R; Hadano S; Shang HF Front Mol Neurosci; 2016; 9():69. PubMed ID: 27582688 [TBL] [Abstract][Full Text] [Related]
16. Muscle microRNA signatures as biomarkers of disease progression in amyotrophic lateral sclerosis. Si Y; Cui X; Crossman DK; Hao J; Kazamel M; Kwon Y; King PH Neurobiol Dis; 2018 Jun; 114():85-94. PubMed ID: 29486297 [TBL] [Abstract][Full Text] [Related]
17. Evaluating the causal association between microRNAs and amyotrophic lateral sclerosis. Zhu Y; Li M; He Z; Pang X; Du R; Yu W; Zhang J; Bai J; Wang J; Huang X Neurol Sci; 2023 Oct; 44(10):3567-3575. PubMed ID: 37261630 [TBL] [Abstract][Full Text] [Related]
18. Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclerosis. Di Pietro L; Lattanzi W; Bernardini C Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29786645 [TBL] [Abstract][Full Text] [Related]
19. Signature of miRNAs derived from the circulating exosomes of patients with amyotrophic lateral sclerosis. Cheng YF; Gu XJ; Yang TM; Wei QQ; Cao B; Zhang Y; Shang HF; Chen YP Front Aging Neurosci; 2023; 15():1106497. PubMed ID: 36845651 [TBL] [Abstract][Full Text] [Related]
20. Key Molecules and Pathways Underlying Sporadic Amyotrophic Lateral Sclerosis: Integrated Analysis on Gene Expression Profiles of Motor Neurons. Lin J; Huang P; Chen W; Ye C; Su H; Yao X Front Genet; 2020; 11():578143. PubMed ID: 33240324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]